Northern Trust Company of Connecticut’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
BIT
Northern Trust Company of Connecticut's REGN Position: Q4 2013 in Review
Northern Trust Company of Connecticut increased its Regeneron Pharmaceuticals (REGN) stake by 12% in Q4 2013, buying an estimated $1.54M and bringing the position to 48,979 shares worth $13.5M. The position accounts for 0.08% of the portfolio, ranked #348.
Northern Trust Company of Connecticut first reported a position in REGN in Q2 2013 and has held it in 3 quarters since. The position peaked at $13.7M in Q3 2013. 438 funds tracked by Wall St. Rank hold REGN as of Q4 2013.
- Northern Trust Company of Connecticut held 48,979 shares of Regeneron Pharmaceuticals worth $13.5M as of Q4 2013.
- Northern Trust Company of Connecticut bought 5,340 Regeneron Pharmaceuticals shares in Q4 2013, an estimated $1.54M.
- Regeneron Pharmaceuticals made up 0.08% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #348 holding.
- Northern Trust Company of Connecticut first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
- Northern Trust Company of Connecticut's Regeneron Pharmaceuticals position peaked at $13.7M in Q3 2013.
- 438 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2013.
Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.